Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
Clinical trial NCT07049159 · RECRUITING
Trial details
- NCT number
- NCT07049159
- Sponsor
- Eveliqure Biotechnologies GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-05-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.